ARAHX
Price
$6.64
Change
+$0.03 (+0.45%)
Updated
Jul 31 closing price
Net Assets
23.63M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

ARAHX vs VSCIX

ARAHX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
ARAHX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAHX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. ARAHX (23.6M). VSCIX pays higher dividends than ARAHX: VSCIX (1.23) vs ARAHX (0.04). ARAHX was incepted earlier than VSCIX: ARAHX (11 years) vs VSCIX (29 years). ARAHX (1.26) is less costly to investors than VSCIX (0.03). ARAHX is a more actively managed with annual turnover of: 26.00 vs. VSCIX (17.00). ARAHX has a lower initial minimum investment than VSCIX: ARAHX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. ARAHX (-0.70). VSCIX return over 5 years is better than : 35.13 vs. ARAHX (-61.98).
ARAHXVSCIXARAHX / VSCIX
Total Expense Ratio1.260.034,200%
Annual Report Gross Expense Ratio1.260.034,200%
Fund Existence11 years29 years-
Gain YTD14.87914.591102%
Front Load4%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets23.6M189B0%
Annual Yield % from dividends0.041.233%
Returns for 1 year-0.7022.58-3%
Returns for 3 years-30.4243.44-70%
Returns for 5 years-61.9835.13-176%
Returns for 10 years-34.69156.07-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C